Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents. [electronic resource]
Producer: 20140811Description: 195-200 p. digitalISSN:- 1569-8041
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Boronic Acids -- administration & dosage
- Bortezomib
- Female
- Glomerular Filtration Rate
- Humans
- Kaplan-Meier Estimate
- Male
- Multiple Myeloma -- complications
- Multivariate Analysis
- Proportional Hazards Models
- Pyrazines -- administration & dosage
- Renal Insufficiency -- etiology
- Risk
- Thalidomide -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.